Lupus

Article	Citations
Investigating the role of IL-6 in the pathogenesis of systemic lupus erythematosus: Insights from bone marrow mesenchymal stem cells	89
Lymphoid interstitial pneumonia in a patient with systemic lupus erythematosus: Case report and literature review	65
Cognitive impairment in a Colombian cohort of patients with systemic lupus erythematosus: A cross-sectional study	56
Predictors for early readmission in patients hospitalized with new onset pediatric lupus nephritis	32
The challenges in diagnosing pediatric primary antiphospholipid syndrome	31
Associations between blood IL-33 levels and IL-33 gene polymorphisms with susceptibility to systemic lupus erythematosus: A meta-analysis	31
Analysis of 5-year hospitalization data of patients with systemic lupus erythematosus: Damage is a risk factor for frequent and longer stays	26
Polyneuritis cranialis as a unique initial presentation of juvenile systemic lupus erythematosus: Case report	25
Fetal proximal and distal limb anomalies following exposure to mycophenolate mofetil during pregnancy: A case report and review of the literature	24
Systemic lupus international collaborating clinics-2012 and European league against rheumatism/American college of rheumatology-2019 classification criteria for systemic lupus erythematosus associated	24
New-onset lupus nephritis associated with COVID-19 infection	24
Severe infections in patients with systemic lupus erythematosus from Tunisia: Prevalence and risk factors	22
Low disease activity state in juvenile-onset systemic lupus erythematosus	22
Neuropsychiatric manifestations are associated with increased mortality in Indian patients with lupus: A single centre retrospective observational study	20
Patient-reported disease impact of systemic lupus erythematosus with active joint symptoms: Results from the systemic lupus erythematosus-update survey	20
Risk of Bloodstream Infection in Patients with Systemic Lupus Erythematosus Exposed to Prolonged Medium-to-High-Dose Glucocorticoids	19
Optical coherence tomography angiography findings of systemic lupus erythematosus patients and the effect of neuropsychiatric involvement on it	19
Intestinal involvement in lupus: From pathophysiology to therapeutic perspectives	18
COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION)	18
Long COVID in patients with systemic lupus erythematosus: A case-control study	18
A qualitative investigation of the experiences of patients living with antiphospholipid antibodies	17
The correlation between pregnancy, disease activity and adverse pregnancy outcomes in patients with systemic lupus erythematosus	17
Exploration of machine learning methods to predict systemic lupus erythematosus hospitalizations	17
An ecological approach to understanding and addressing health inequities of systemic lupus erythematosus	16
Naomi Rothfield, MD, MACR 1929-2023	16

Evaluation of self-report screening measures in the detection of depressive and anxiety disorders among children and adolescents with systemic lupus erythematosus	16
Hematological involvement in pediatric systemic lupus erythematosus: A multi-center study	16
Considering belimumab during pregnancy: A more viable option over time	16
Risk of adverse pregnancy outcomes in Japanese systemic lupus erythematosus patients with prior severe organ manifestations: A single-center retrospective analysis	15
Prevalence of migraine in systemic lupus erythematosus: A meta-analysis	15
Repeat kidney biopsy findings of lupus nephritis patients in clinical remission treated with Mycophenolate associated with Belimumab or Mycophenolate plus standard of care therapy. A “post-hoc” analys	15
Risk factors associated with COVID-19 in systemic lupus erythematosus: Results from a longitudinal prospective cohort	15
Exploring the role of LIAS-related cuproptosis in systemic lupus erythematosus	15
DNA methylation alterations in systemic lupus erythematosus: A systematic review of case-control studies	14
Ocular involvement in primary antiphospholipid syndrome: results of an extensive ophthalmological evaluation performed in the APS-Rio cohort	14
Exploring gastrointestinal manifestations in childhood onset systemic lupus erythematosus - Insights from a multicenter study	14
Depression in systemic lupus erythematosus: A manifestation of microcirculation dysfunction?	14
Electronic health record data use in the assessment of quality indicators for glucocorticoid osteoporosis screening in systemic lupus erythematosus	13
Obinutuzumab in patients with repeated lupus nephritis flares: A case series	13
Thanks to Reviewers	13
Growth arrest-specific protein 6 as a marker of nephritis in systemic sclerosis and juvenile systemic lupus erythematosus patients	13
The use of belimumab on patients with both systemic lupus erythematosus and immune thrombocytopenia: A retrospective cohort study	13
Time to diagnosis in systemic lupus erythematosus: Associated factors and its impact on damage accrual and mortality. Data from a multi-ethnic, multinational Latin American lupus cohort	12
Reversible dilated cardiomyopathy in systemic lupus erythematosus: A case report	12
Serologic phenotypes distinguish systemic lupus erythematosus patients developing interstitial lung disease and/or myositis	11
Estimating glucocorticoid-related morbidity in lupus nephritis using the glucocorticoid toxicity index	11
Systemic lupus erythematosus is associated with increased risk of mortality and acute kidney injury in patients with COVID-19 hospitalization: Insights from a National Inpatient Sample analysis	11
Factors associated with non-adherence to medications in systemic lupus erythematosus: Results from a Swedish survey	11
Downregulation of circETS1 disrupts Th17/Treg homeostasis by inhibiting FOXP3 transcription: A new potential biomarker in systemic lupus erythematosus	11
Steroid-free flare management of a severe cutaneous lupus flare with anifrolumab	11
Induction treatment for lupus nephritis at a high-complexity hospital in Chile	11
The new 2019-EULAR/ACR classification criteria specific domains at diagnosis can predict damage accrual in 670 childhood-onset systemic lupus erythematosus patients	11
Advances in the study of exosome-derived miRNAs in the pathogenesis, diagnosis, and treatment of systemic lupus erythematosus	11
Relationship between serum lipopolysaccharide binding protein levels, disease activity, and clinical characteristics in Paraguayan patients with systemic lupus erythematosus	11
Systemic lupus erythematosus with diffuse intracranial calcification: A case report and review of literature	11
Dietary patterns and life-styles of patients with gastrointestinal involvement of systemic lupus erythematosus: Questionnaire survey from a tertiary center of China	10
Comparison of hydroxychloroquine titers measured in frozen/thawed serum and whole blood obtained from lupus patients	10
Real-world treatment patterns of immunosuppressants in Adults with systemic lupus erythematosus: A claims database analysis in the United States	10
Different patterns of longitudinal changes in antinuclear antibodies titers in children with systemic lupus erythematosus and Sjögren's syndrome	10
Analysis of clinical, immunological characteristics, damage, and survival in 300 Turkish systemic lupus erythematosus patients	10
Factors mediating cancer risk in systemic lupus erythematosus	10
Exposure levels of mycophenolic acid are associated with comorbidities in children with systemic lupus erythematosus	10
Early onset left ventricular remodeling in juvenile systemic lupus erythematosus; Insight from 3-dimensional speckle tracking echocardiography	10
The Type 1 & 2 systemic lupus erythematosus model: Perspectives of people living with systemic lupus erythematosus	10
Pulmonary thromboembolism and alveolar hemorrhage as initial manifestations of systemic lupus erythematosus	10
Capillaroscopic findings in systemic lupus erythematosus with cutaneous digital lesions	10
Ventricular-arterial coupling in systemic lupus erythematosus women without cardiovascular risk factors	10
The (reverse) paradox of lupus anticoagulant: A case report	10
Antiphospholipid syndrome in patients over 65 years: A comparative study of clinical and biological features and thrombotic relapses	10
Does the standard proteinuria cut-off for renal biopsy in lupus nephritis as per the current guidelines hold good for Asian population? A single-centre study from South India	10
Patient-reported outcome measures in systemic lupus erythematosus by a web-based application: A randomized, crossover, agreement study	9
Clinical characteristics of itch in cutaneous lupus erythematosus: A prospective, multicenter, multinational, cross-sectional study	9
Epidemiology and outcomes of emergency department visits in systemic lupus erythematosus: Insights from the nationwide emergency department sample (NEDS)	9
Omega-3 fatty acids: Current insights into mechanisms of action in systemic lupus erythematosus	9
Efficacy of cyclosporine in a patient with lupus mesenteric vasculitis refractory to conventional immunosuppressive therapy	9

Association between cognitive impairment and olfactory deficits in systemic lupus erythematosus without major neuropsychiatric syndromes	9
Research progress in functional magnetic resonance imaging assessment of lupus nephritis kidney injury	9
Long-term outcome and predictors of long-term outcome in patients with lupus nephritis managed at a tertiary hospital in Mumbai	9
Summary of the 12th Meeting of the European Forum on antiphospholipid antibodies ONLINE	9
Progenitor cells and circulating endothelial cells are associated with disease activity and damage in systemic lupus erythematosus patients	9
Differences and similarities of proliferative and non-proliferative forms of biopsy-proven lupus nephritis: Single centre, cross-disciplinary experience	9
T cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain as a promising immune checkpoint target for the treatment of SLE	9
Risk stratification for infection during immunosuppressive therapy in patients with lupus nephritis: A nested case-control study	9
Systemic lupus erythematosus and antiphospholipid syndrome with retiform purpura as the initial skin lesion: A case study	9
A 5–year follow-up of pulmonary function tests in childhood-onset systemic lupus erythematosus: a single-center retrospective study	9
Porphyromonas gingivalis amount in the tongue biofilm is associated with erosive arthritis in systemic lupus erythematosus	9
Membranous lupus nephritis secondary to secukinumab therapy: A case report and literature review	9
Reduced circulating Tregs and positive pANCA were robustly associated with the occurrence of antiphospholipid syndrome in patients with systemic lupus erythematosus	9
Adherence patterns to medications and their association with subsequent hospitalization in adult Egyptian patients with systemic lupus erythematosus	9
Anti-SARS-CoV-2 mRNA vaccination among patients living with SLE in Sweden: Coverage and clinical effectiveness	8
Factors associated with poor outcomes in SLE patients with COVID-19: Data from ReumaCoV-Brazil register	8
Validity and reliability of patient reported outcomes measurement information system computerized adaptive tests in systemic lupus erythematous	8
Premature ovarian failure in juvenile systemic lupus erythematosus patient: A rare presentation	8
Predictive model of risk and severity of enteritis in systemic lupus erythematosus	8
Epidemiology of disease-activity related ophthalmological manifestations in Systemic Lupus Erythematosus: A systematic review	8
Twenty-year trends in all-cause mortality of patients with systemic lupus erythematosus in Mexico: Results from a nationwide health registry	8
Proportion, domains, and risk factors of cognitive impairment in systemic lupus erythematosus	8
Adverse drug reactions to trimethoprim-sulfamethoxazole in systemic lupus erythematosus	8
Disease exacerbation and COVID-19 following mRNA COVID-19 vaccination in adolescents with Systemic Lupus Erythematosus	8
A novel long noncoding RNA ENST00000597482 serves as a potential biomarker for disease activity and diagnosis of systemic lupus erythematosus	8
Non-pharmacologic therapies in treatment of childhood-onset systemic lupus erythematosus: A systematic review	8
Plasma osteopontin versus intima media thickness of the common carotid arteries in well-characterised patients with systemic lupus erythematosus	8
Prognostic factors of systemic lupus erythematosus patients with pulmonary embolism: An 11-year cohort study	8
Does hydroxychloroquine improve patient reported outcomes in patients with lupus?	7
Cost-effectiveness analysis of treatments for the first episode of catastrophic antiphospholipid syndrome: A study based on the catastrophic antiphospholipid syndrome registry	7
Korean LupusPRO: Cross-Cultural validation study for systemic lupus erythematosus	7
Mitochondrial bioenergetic changes in systemic lupus erythematosus immune cell subsets: Contributions to pathogenesis and clinical applications	7
Principles of pediatric lupus nephritis in a prospective contemporary multi-center cohort	7
Network pharmacology and molecular docking to elucidate the common mechanism of hydroxychloroquine treatment in lupus nephritis and IgA nephropathy	7
Non-invasive prediction of the chronic degree of lupus nephropathy based on ultrasound radiomics	7
Urine β-2-glycoprotein 1 as a biomarker for diagnosis of systemic lupus erythematosus	7
Oral lesions of systemic lupus erythematosus: A collaborative Latin American study	7
Systemic lupus erythematosus-related acute lung disease	7
Alterations of spontaneous brain activity in systematic lupus erythematosus patients without neuropsychiatric symptoms: A resting-functional MRI study	7
The association between lupus serology and disease outcomes: A systematic literature review to inform the treat-to-target approach in systemic lupus erythematosus	7
Cytomegalovirus infection and disease in systemic lupus erythematosus patients at a high-complexity hospital in southwestern Colombia	7
Lupus, antiphospholipid syndrome, and stroke: An attempt to crossmatch	7
Evaluation of thyroid dysfunction in childhood-onset systemic lupus erythematosus: Risk factors for Hashimoto’s thyroiditis	7
MBL2 gene polymorphisms and its relation to infection in Brazilian systemic lupus erythematosus patients: A 10-years follow-up study	7
A single-center model for implementation of SLEDAI documentation adherence in childhood-onset systemic lupus erythematosus (cSLE)	7
Correspondence on “relationship between the EULAR/ACR classification criteria and organ damage in systemic lupus erythematosus” by Chi Chiu Mok et al	7
Primary antiphospholipid syndrome with and without limb ischemia: A retrospective observational study	7
A rare case of late-onset spondyloenchondrodysplasia with immune dysregulation presenting as adult-onset monogenic lupus	7
Serum long non-coding Ribonucleic Acid H19 serves as a biomarker for systemic lupus erythematosus and participates in the disease progression	7
Complement C4d as a biomarker for systemic lupus erythematosus and lupus nephritis	7
Determinants of sexual function in male patients with systemic lupus erythematosus	7
Regarding the efficacy of the COVID-19 vaccine in pediatric systemic lupus erythematosus patient	7
Cross-sectional study of plasma Axl, ferritin, IGFBP4 and sTNFR2 as biomarkers of disease activity in childhood-onset SLE: A study of the Pediatric Nephrology Research Consortium	7
Higher body mass index and disease duration are associated with increased risk of left ventricular diastolic dysfunction in women with systemic lupus erythematosus	7
Early diagnosis of lupus: A possibilty. A multicentric study from SLE Special Interest Group (SIG) of Indian Rheumatology Association (IRA)	7
Health care utilization and costs of systemic lupus erythematosus in the United States: A systematic review	7
The effect of community-acquired pneumonia on myocardial injury in systemic lupus erythematosus: Insights from cardiac magnetic resonance	7
Combining maintenance therapy with hydroxychloroquine increases LLDAS achievement rates in individuals with stable systemic lupus erythematosus	7
Tofacitinib versus thalidomide for mucocutaneous lesions of systemic lupus erythematosus: A real-world CSTAR cohort study XXVII	7
Bacteremia in systemic lupus erythematosus: Risk factors, clinical and microbiological characteristics, and outcomes in the largest single-center retrospective cohort in Japan	7
Risk factors of pulmonary arterial hypertension in patients with systemic lupus erythematosus: A meta-analysis	7
Are autoimmune diseases autoinflammatory: Is it time to change the paradigm?	6
Development and psychometric properties of the Reproductive Health Assessment in Systemic Lupus Erythematosus: Mixed-Methods study	6
Abnormal presentation of pregnancy and postpartum initial-onset systemic lupus erythematosus combined with diffuse alveolar hemorrhage: A case report	6
Corrigendum to The landscape of systemic lupus erythematosus in Brazil: An expert panel review and recommendations	6
Detection of genetic mutations underlying early-onset systemic lupus erythematosus	6
Parkinsonism as the presenting manifestation of lupus: A case-based review	6
Anifrolumab for systemic lupus erythematosus with multi-refractory skin disease: A case series of 18 patients	6
Literature review of lupus nephritis From the Arabian Gulf region	6
Drug-induced lupus erythematosus in childhood: Case-based review	6
Clinicopathologic features in childhood-onset lupus nephritis with antineutrophil cytoplasmic antibody positivity——a multi-center retrospective study	6
Cell activation, PD-1 expression and in vitro cytokine production in patients with juvenile systemic lupus erythematosus	6
Comparison of efficacy of continuous mycophenolate mofetil with sequential cyclophosphamide and tacrolimus as maintenance therapy for lupus nephritis	6
Ophthalmologic manifestations in patients with antiphospholipid antibodies: Beware of iatrogenic complications	6
Social impact of disease parameters and damage accrual in adult Brazilian patients with childhood-onset Systemic Lupus Erythematosus	6
The high expression of miR-564 in patients with systemic lupus erythematosus promotes differentiation and maturation of DC cells by negatively regulating TP53 expression in vitro	6
Association of juvenile systemic lupus erythematosus and retinal vasculitis: Genetic aspects	6
Skin and beyond: Demographics, clinical features and systemic involvement of cutaneous lupus erythematosus in Pakistani population	6
Retrospective cohort study identifying pulmonary complications in a cohort of patients with systemic lupus erythematosus	6
Treatment adherence and quality of life in colombian patients with lupus nephritis	6

Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: Data from the UK Juvenile-onset systemic lupus erythematosus cohort study	6
Healthcare costs of systemic lupus erythematosus in New Zealand	6
High density lipoprotein influences CD4 T cell proliferation in Systemic Lupus Erythematosus and increases TGF-β1 expression: A potential role in the protection from atherosclerosis and autoimmunity	6
Examination of antinuclear antibody staining patterns and titers in patients with childhood-onset systemic lupus erythematosus	6
Skin erythematous migrant lesions consistent with histologically confirmed dermal arteriolar thrombosis connected to APS	6
Association between interferon-I producing plasmacytoid dendritic cells and thrombotic antiphospholipid syndrome	6
Dyslipidemia is insufficiently treated in antiphospholipid syndrome patients	6
LncRNA NRIR serves as a biomarker for systemic lupus erythematosus and participates in the disease progression	6
Life expectancy and death pattern associated with systemic lupus erythematosus diagnosis in Brazil between 2000 and 2019	6
The experience and implications of pain in systemic lupus erythematosus: A qualitative interview study focusing on the patient’s perspective	6
Real world application of the 2023 ACR/EULAR antiphospholipid antibody syndrome classification criteria in a pharmacist directed anticoagulation clinic	6
Lack of awareness of systemic lupus erythematosus and its consequences in a cohort of moderate and severe patients in Spain: The LupusVoice study	6
Neonatal Fc receptor expression in lymphoid and myeloid cells in systemic lupus erythematosus	6
Sustained depression of B cell counts in lupus nephritis after treatment with rituximab and/or belimumab is associated with fewer disease flares	6
Factors detrimental to work productivity and daily activities in systemic lupus erythematosus patients – Analysis of the German LuLa study	6
Lupus anticoagulant-hypoprothrombinemia syndrome in children: Three case reports and systematic review of the literature	5
Systematic literature review of intravenous immunoglobulin use in non-renal and non-hematologic systemic lupus erytehmatosus	5
The impact of curcumin supplementation on systemic lupus erythematosus and lupus nephritis: A systematic review	5
Impact of perception of illness on quality of life in juvenile systemic lupus erythematosus	5
Diving deep into lupus: Gastrointestinal involvement insights from the Oman lupus study	5
Clinical efficacy of centrifugal-membranous hybrid double filtration plasmapheresis and membranous double filtration plasmapheresis on severe lupus nephritis	5
Insertion/deletion polymorphism of the angiotensin-converting enzyme gene in lupus nephritis at Cho Ray hospital, Vietnam	5
Juvenile neuropsychiatric systemic lupus erythematosus: A specific clinical phenotype and proposal of a probability score	5
The efficacy of induction treatment in Thai patients with lupus nephritis: Observational cohort analysis	5
Systemic lupus erythematosus and toll-like receptor 9 polymorphisms: A meta-analysis of genetic association studies	5
Bilateral outer foveal microdefect in a patient with systemic lupus erythematosus using hydroxychloroquine - A case report	5
Trends in all-cause hospitalizations for systemic lupus erythematosus in Mexico, 2000–2019	5
A review of the development of gangrene in patients with systemic lupus erythematosus – A 44-year follow-up study	5
Predictive value of Doppler echocardiography parameters for cardiovascular events in patients with systemic lupus erythematosus	5
Incidence and prevalence of systemic lupus erythematosus in New Zealand from the national administrative datasets	5
Laryngeal and voice dysfunction in systemic lupus erythematosus patients – A case-control study	5
Ablation of SigH+ pDCs in B6.Nba2 mice prevents lupus-like disease development only if started before disease is fully established	5
APOL1 and the risk of adverse renal outcomes in patients of African ancestry with systemic lupus erythematosus	5
Health-Related Quality of Life and fatigue are associated with a higher work productivity impairment in systemic lupus erythematosus patients: Data from the Almenara Lupus Cohort	5
A significant improvement of thromboses treated by a new oral anticoagulant in an 11-year-old girl with systemic lupus erythematosus associated antiphospholipid syndrome: A case report	5
Utility of pan-immune-inflammation value as a predictor of the prognosis of childhood lupus	5
The relationship between the modified National Institute of Health activity and chronicity scoring system, and the long-term prognosis for lupus nephritis: A retrospective single-center study	5
Expression pattern of tissue-resident memory T cells in cutaneous lupus erythematosus	5
Phenotype and disease course differences in monogenic and sporadic childhood lupus	5
The effectiveness of telitacicept in patients with systemic lupus erythematosus: A retrospective, real-world study	5
COVID-19 in systemic lupus erythematosus: A pooled analysis and systematic review of case reports and series	5
The potential use of serum interleukin-21 as biomarker for lupus nephritis activity compared to cytokines of the tumor necrosis factor (TNF) family	5
Factors affecting sleep quality in patients with systemic lupus erythematosus	5
A home-based exercise program during COVID-19 pandemic: Perceptions and acceptability of juvenile systemic lupus erythematosus and juvenile idiopathic arthritis adolescents.	5
The efficacy and safety of telitacicept for the treatment of systemic lupus erythematosus: a real life observational study	5
Renal function deterioration is an independent mortality determinant in Koreans diagnosed with lupus nephritis	5
Interferon-gamma (IFN-γ) intronic variant (rs2430561) is a risk factor for systemic lupus erythematosus: Observation from a meta-analysis	5
Systemic lupus erythematosus children in Egypt: Homeland spectrum amid the global situation	5
Status of TWEAK DNA methylation and mRNA expression in systemic lupus erythematosus	5
Dilemma of belimumab therapy (dis)continuation during pregnancy: Results of a retrospective study in eudravigilance	5
Risk of osteonecrosis in systemic lupus erythematosus: An 11-year Chinese single-center cohort study	5
What you need to know about migraine in Hughes syndrome patients	5
Efficacy of Telitacicept in a systemic lupus erythematosus patient with suboptimal response to Belimumab: A case report	5
Validation and adaptation of the Spanish version of the systemic lupus activity questionnaire (S-SLAQ) in an Argentinean population	5
Psychological and quality of life effects of vaccination against COVID-19 in patients with systemic autoimmune diseases	5
Association of the premature immunosenescence with the presence and severity of anemia among patients with systemic lupus erythematosus	5